CB45562-21 - 0x0000000000006522
Males & Females of Non-Childbearing Potential
Mountain
* Stipend may pay up to reflected amount.
Start Date:
February 16, 2025 - 3:15pm
End Date:
March 10, 2025 - 1:45pm
Study Details
Study Number: CB45562
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease
Route of Administration: Oral
Blood Draws: 35
Study Schedule
Schedule Type: Long Term
Study Length: 10 Night Stay & 1 Phone Call
Screening Dates:
Event Day | Event Date |
---|---|
Tuesday | 2/11/2025 |
Thursday | 2/13/2025 |
Friday | 2/14/2025 |
Saturday | 2/15/2025 |
Doctor Exam Dates:
Event Day | Event Date |
---|---|
Tuesday | 2/11/2025 |
Thursday | 2/13/2025 |
Friday | 2/14/2025 |
Saturday | 2/15/2025 |
Study Dates:
Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
---|---|---|---|---|---|---|
Check-In | Sunday | 2/16/2025 3:15:00 PM | Wednesday | 2/26/2025 9:45:00 AM | 1 | Lincoln |
Phone participant | Monday | 3/10/2025 1:45:00 PM | 1 | Lincoln |